Prodrugs of hydroxamate-based GCPII inhibitors
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F24%3A00587528" target="_blank" >RIV/61388963:_____/24:00587528 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/patent/search/family/062145840/publication/US11866394B2?q=US11866394B2" target="_blank" >https://worldwide.espacenet.com/patent/search/family/062145840/publication/US11866394B2?q=US11866394B2</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Prodrugs of hydroxamate-based GCPII inhibitors
Original language description
Prodrugs of hydroxamate-based GCPII inhibitors and methods of their use for treating a disease or condition are disclosed.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
10401 - Organic chemistry
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
US11866394
Publisher
US001 -
Publisher name
United States Patent and Trademark Office (USPTO)
Place of publication
Alexandria
Publication country
US - UNITED STATES
Date of acceptance
Jan 9, 2024
Owner name
The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i.
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence